Lite Strategy LITS
NASDAQ LITS
$0.94 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

Lite Strategy (LITS) EBT Margin (2016 - 2023)

Lite Strategy (LITS) posted quarterly EBT Margin of 81.11% for Q3 2023, up 49136.0% year-over-year from N/an in Q3 2022, and up 111.17% quarter-over-quarter from 726.42% in Q2 2023.

Lite Strategy (LITS) EBT Margin (2016 - 2023) Analysis & Trends

Lite Strategy's EBT Margin history runs 8 years deep, the most recent figure standing at 81.11% for Q3 2023.

  • In Q3 2023, EBT Margin rose 49136.0% year-over-year to 81.11%; the TTM figure through Jun 2024 stood at 2.11% (up 15195.0% YoY), while the FY2024 annual figure was 6.44%, up 23100.0% from the prior year.
  • EBT Margin for Q3 2023 stood at 81.11%, up from 726.42% in the prior quarter.
  • The five-year high for EBT Margin was 81.11% in Q3 2023, with the low at 4429.32% in Q2 2019.
  • The 5-year median for EBT Margin is 322.01% (2021), against an average of 708.45%.
  • The sharpest annual moves came in 2020 and 2021: EBT Margin soared 447558 bps in 2020, then tumbled 97418 bps in 2021.
  • Lite Strategy's EBT Margin stood at 1430.43% in 2019, then soared by 85 bps to 214.7% in 2020, then rose by 17 bps to 177.93% in 2021, then jumped by 110 bps to 17.2% in 2022, then surged by 372 bps to 81.11% in 2023.
  • Business Quant data shows LITS's EBT Margin at 81.11% in Q3 2023, 726.42% in Q2 2023, and 549.32% in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 41.75%
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 35.61%
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 35.71%
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -528.97%
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 18.33%
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 13.77%
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -2.67%
8 Royalty Pharma 26.98 Bn 26.14 Bn - 12.09%
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -25.06%
10 Lite Strategy 33.69 Mn 26.14 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2023 81.11%
Jun 30, 2023 -726.42%
Mar 31, 2023 -549.32%
Dec 31, 2022 17.20%
Sep 30, 2022 -410.25%
Jun 30, 2022 -143.42%
Mar 31, 2022 -225.69%
Dec 31, 2021 -177.93%
Sep 30, 2021 -312.35%
Jun 30, 2021 -927.92%
Mar 31, 2021 -322.01%
Dec 31, 2020 -214.70%
Sep 30, 2020 -291.14%
Jun 30, 2020 46.26%
Mar 31, 2020 -998.25%
Dec 31, 2019 -1,430.43%
Sep 30, 2019 -1,102.06%
Jun 30, 2019 -4,429.32%
Mar 31, 2019 -1,344.00%
Dec 31, 2018 -712.16%